Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Complications of BCG vaccine SSI® recent story and risk management plan: the French experience.

Chol C, Guy C, Jacquet A, Castot-Villepelet A, Kreft-Jais C, Cambazard F, Beyens MN, Mounier G, Marsille F, Mismetti P.

Pharmacoepidemiol Drug Saf. 2013 Apr;22(4):359-64. doi: 10.1002/pds.3383. Epub 2012 Dec 5.

PMID:
23213021
2.

[French survey about intradermal BCG SSI adverse events in children under 6 years of age].

Dommergues MA, de la Rocque F, Dufour V, Floret D, Gaudelus J, Guérin N, Le Sage FV, Bocquet A, Cohen R.

Arch Pediatr. 2007 Jan;14(1):102-8. Epub 2006 Nov 30. French. Erratum in: Arch Pediatr. 2007 Apr;14(4):415.

PMID:
17140780
3.

Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database.

Michenot F, Sommet A, Bagheri H, Lapeyre-Mestre M, Montastruc JL; French Network of PharmacoVigilance Centres..

Pharmacoepidemiol Drug Saf. 2006 Oct;15(10):735-40.

PMID:
16924603
4.

A comparative study of adverse drug reactions during two heat waves that occurred in France in 2003 and 2006.

Sommet A, Durrieu G, Lapeyre-Mestre M, Montastruc JL; Association of French PharmacoVigilance Centres..

Pharmacoepidemiol Drug Saf. 2012 Mar;21(3):285-8. doi: 10.1002/pds.2307. Epub 2011 Dec 8.

PMID:
22162094
5.

Effect of an intervention on the features of adverse drug reactions spontaneously reported in a hospital.

Cereza G, Agustí A, Pedrós C, Vallano A, Aguilera C, Danés I, Vidal X, Arnau JM.

Eur J Clin Pharmacol. 2010 Sep;66(9):937-45. doi: 10.1007/s00228-010-0856-8. Epub 2010 Jun 16.

PMID:
20552176
6.

Investigations into an outbreak of suppurative lymphadenitis with BCG vaccine SSI(®) in Singapore.

Soh SB, Han PY, Tam KT, Yung CF, Liew WK, Tan NW, Chong CY, Thoon KC.

Vaccine. 2014 Oct 7;32(44):5809-15. doi: 10.1016/j.vaccine.2014.08.032. Epub 2014 Aug 27.

PMID:
25173482
7.

[Meningococcal serogroup C vaccine: a pharmacovigilance point of view].

Bagheri H, Gony M, Montastruc JL.

Therapie. 2005 May-Jun;60(3):287-94. French.

PMID:
16130227
8.

Bevacizumab-induced serious side-effects: a review of the French pharmacovigilance database.

Taugourdeau-Raymond S, Rouby F, Default A, Jean-Pastor MJ; French Network of Pharmacovigilance Centers..

Eur J Clin Pharmacol. 2012 Jul;68(7):1103-7. doi: 10.1007/s00228-012-1232-7. Epub 2012 Feb 16.

PMID:
22349162
9.

Overview of adverse reactions to nefopam: an analysis of the French Pharmacovigilance database.

Durrieu G, Olivier P, Bagheri H, Montastruc JL; French Network of Pharmacovigilance Centers..

Fundam Clin Pharmacol. 2007 Oct;21(5):555-8.

PMID:
17868209
10.

[Adverse events following immunization with BCG vaccine in Poland 1994-2000].

Szczuka I.

Przegl Epidemiol. 2002;56(2):205-16. Polish.

PMID:
12371352
11.

[Use of Nadis(®) software to improve adverse drug reaction reporting of antiretroviral drugs: experience in south west of France (midi-pyrénées)].

Pochard L, Hauviller L, Cuzin L, Eyvrard F, Sommet A, Montastruc JL, Bagheri H.

Therapie. 2014 Mar-Apr;69(2):149-55. doi: 10.2515/therapie/2013076. Epub 2014 Jun 12. French.

PMID:
24926633
12.

Reporting rate of adverse drug reactions to the French pharmacovigilance system with three step 2 analgesic drugs: dextropropoxyphene, tramadol and codeine (in combination with paracetamol).

Tavassoli N, Lapeyre-Mestre M, Sommet A, Montastruc JL; French Association of Regional Pharmacovigilance Centres..

Br J Clin Pharmacol. 2009 Sep;68(3):422-6. doi: 10.1111/j.1365-2125.2009.03472.x.

13.

Was the thrombotic risk of rofecoxib predictable from the French Pharmacovigilance Database before 30 September 2004?

Sommet A, Grolleau S, Bagheri H, Lapeyre-Mestre M, Montastruc JL; French Network of Regional Pharmacovigilance Centres..

Eur J Clin Pharmacol. 2008 Aug;64(8):829-34. doi: 10.1007/s00228-008-0497-3. Epub 2008 May 29.

PMID:
18509626
14.

New guideline for tramadol usage following adverse drug reactions reported to the Iranian Pharmacovigilance Center.

Gholami K, Shalviri G, Zarbakhsh A, Daryabari N, Yousefian S.

Pharmacoepidemiol Drug Saf. 2007 Feb;16(2):229-37.

PMID:
17063533
15.

Importance of cytochrome P450 (CYP450) in adverse drug reactions due to drug-drug interactions: a PharmacoVigilance study in France.

Danton AC, Montastruc F, Sommet A, Durrieu G, Bagheri H, Bondon-Guitton E, Lapeyre-Mestre M, Montastruc JL.

Eur J Clin Pharmacol. 2013 Apr;69(4):885-8. doi: 10.1007/s00228-012-1394-3. Epub 2012 Sep 21.

PMID:
22996074
16.

The importance of drug-drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France.

Montastruc F, Sommet A, Bondon-Guitton E, Durrieu G, Bui E, Bagheri H, Lapeyre-Mestre M, Schmitt L, Montastruc JL.

Eur J Clin Pharmacol. 2012 May;68(5):767-75. doi: 10.1007/s00228-011-1156-7. Epub 2011 Nov 25.

PMID:
22116460
17.

[Pharmacovigilance of vaccines].

Autret-Leca E, Bensouda-Grimaldi L, Jonville-Béra AP, Beau-Salinas F.

Arch Pediatr. 2006 Feb;13(2):175-80. Epub 2005 Dec 15. Review. French.

PMID:
16343870
18.

Outbreak of Bacille Calmette-Guérin-related lymphadenitis in Saudi children at a university hospital after a change in the strain of vaccine.

Alrabiaah AA, Alsubaie SS, Bukhari EI, Gad A, Alzamel FA.

Ann Saudi Med. 2012 Jan-Feb;32(1):4-8.

PMID:
22156633
19.

Gender differences in adverse drug reactions: analysis of spontaneous reports to a Regional Pharmacovigilance Centre in France.

Montastruc JL, Lapeyre-Mestre M, Bagheri H, Fooladi A.

Fundam Clin Pharmacol. 2002 Oct;16(5):343-6.

PMID:
12608357
20.

Local and regional adverse reactions to BCG-SSI vaccination: a 12-month cohort follow-up study.

Dommergues MA, de La Rocque F, Guy C, Lécuyer A, Jacquet A, Guérin N, Fagot JP, Boucherat M, d'Athis P, Cohen R.

Vaccine. 2009 Nov 23;27(50):6967-73. doi: 10.1016/j.vaccine.2009.09.073. Epub 2009 Oct 1. Review.

PMID:
19800440

Supplemental Content

Support Center